WO2004024949A3 - Procede de detection rapide de mutations et de polymorphismes nucleotidiques par chimiometrie - Google Patents

Procede de detection rapide de mutations et de polymorphismes nucleotidiques par chimiometrie Download PDF

Info

Publication number
WO2004024949A3
WO2004024949A3 PCT/DK2003/000594 DK0300594W WO2004024949A3 WO 2004024949 A3 WO2004024949 A3 WO 2004024949A3 DK 0300594 W DK0300594 W DK 0300594W WO 2004024949 A3 WO2004024949 A3 WO 2004024949A3
Authority
WO
WIPO (PCT)
Prior art keywords
mutations
analysis
chemometrics
probe
nucleotide polymorphisms
Prior art date
Application number
PCT/DK2003/000594
Other languages
English (en)
Other versions
WO2004024949A2 (fr
Inventor
Mogens Fenger
Original Assignee
Hvidovre Hospital
Mogens Fenger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hvidovre Hospital, Mogens Fenger filed Critical Hvidovre Hospital
Priority to EP03794827A priority Critical patent/EP1567673A2/fr
Priority to AU2003260294A priority patent/AU2003260294A1/en
Publication of WO2004024949A2 publication Critical patent/WO2004024949A2/fr
Publication of WO2004024949A3 publication Critical patent/WO2004024949A3/fr

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00Machine learning
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/02Neural networks
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection

Abstract

L'invention concerne des procédés, des trousses et des systèmes permettant de déterminer la présence ou l'absence de polynucléotides cibles par hybridation avec des sondes polynucléotidiques comprenant une étiquette détectable suivie d'une analyse spectrale, de préférence une analyse multivariable. L'analyse spectrale permet de déterminer si la sonde fait ou non partie d'un polynucléotide hybride et, par conséquent, si le polynucléotide cible est présent ou non. De plus, l'analyse des données spectrales permet de déterminer, dans le cas où la sonde appartient à un polynucléotide hybride, s'il existe ou non un ou plusieurs mésappariements entre la sonde et la cible. Ces procédés, trousses et systèmes peuvent servir à déterminer des mutations et des polymorphismes.
PCT/DK2003/000594 2002-09-13 2003-09-12 Procede de detection rapide de mutations et de polymorphismes nucleotidiques par chimiometrie WO2004024949A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03794827A EP1567673A2 (fr) 2002-09-13 2003-09-12 Procede de detection rapide de mutations et de polymorphismes nucleotidiques par chimiometrie
AU2003260294A AU2003260294A1 (en) 2002-09-13 2003-09-12 Method of rapid detection of mutations and nucleotide polymorphisms using chemometrics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200201351 2002-09-13
DKPA200201351 2002-09-13

Publications (2)

Publication Number Publication Date
WO2004024949A2 WO2004024949A2 (fr) 2004-03-25
WO2004024949A3 true WO2004024949A3 (fr) 2004-05-27

Family

ID=31984970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2003/000594 WO2004024949A2 (fr) 2002-09-13 2003-09-12 Procede de detection rapide de mutations et de polymorphismes nucleotidiques par chimiometrie

Country Status (3)

Country Link
EP (1) EP1567673A2 (fr)
AU (1) AU2003260294A1 (fr)
WO (1) WO2004024949A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1591535A1 (fr) * 2004-04-29 2005-11-02 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO Classification d'organismes basée sur l'utilisation de réseaux représentant des génomes
US20070292860A1 (en) * 2004-04-29 2007-12-20 Schuren Frank H J Staphylococcus Aureus Specific Diagnostics
DE102008059985B3 (de) * 2008-12-02 2010-04-01 Ip Bewertungs Ag Real-Time-PCR mittels Gigahertz- oder Terahertz-Spektrometrie
US9169515B2 (en) 2010-02-19 2015-10-27 Life Technologies Corporation Methods and systems for nucleic acid sequencing validation, calibration and normalization
KR101184566B1 (ko) * 2012-05-11 2012-09-20 케이맥(주) 실시간 중합효소 연쇄반응과 dna 칩이 통합된 검사 시스템 및 이를 이용한 통합 분석방법
US20140272946A1 (en) * 2013-03-15 2014-09-18 Src, Inc. Methods and Systems For DNA-Based Detection And Reporting
CN113580099B (zh) * 2021-06-21 2022-10-14 东南大学 一种编码式纳米机器及其控制、制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633134A (en) * 1992-10-06 1997-05-27 Ig Laboratories, Inc. Method for simultaneously detecting multiple mutations in a DNA sample
US5635352A (en) * 1993-12-08 1997-06-03 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise
US5849486A (en) * 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
US6048690A (en) * 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US6261782B1 (en) * 1999-04-06 2001-07-17 Yale University Fixed address analysis of sequence tags
US6341257B1 (en) * 1999-03-04 2002-01-22 Sandia Corporation Hybrid least squares multivariate spectral analysis methods
US6584413B1 (en) * 2001-06-01 2003-06-24 Sandia Corporation Apparatus and system for multivariate spectral analysis
US6675106B1 (en) * 2001-06-01 2004-01-06 Sandia Corporation Method of multivariate spectral analysis

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048690A (en) * 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US5633134A (en) * 1992-10-06 1997-05-27 Ig Laboratories, Inc. Method for simultaneously detecting multiple mutations in a DNA sample
US5849486A (en) * 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
US5635352A (en) * 1993-12-08 1997-06-03 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise
US6341257B1 (en) * 1999-03-04 2002-01-22 Sandia Corporation Hybrid least squares multivariate spectral analysis methods
US6261782B1 (en) * 1999-04-06 2001-07-17 Yale University Fixed address analysis of sequence tags
US6584413B1 (en) * 2001-06-01 2003-06-24 Sandia Corporation Apparatus and system for multivariate spectral analysis
US6675106B1 (en) * 2001-06-01 2004-01-06 Sandia Corporation Method of multivariate spectral analysis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KURT VARMUZA: "Chemometrics: Statistics and Multivariate Data Analysis in Chemistry - Application Examples", INT. CONF. ON STATISTICS AND RELATED FIELDS, 5 June 2003 (2003-06-05) - 9 June 2003 (2003-06-09), Honolulu, Hawaii 2003, pages 1 - 29, XP002267859 *
LEE K R ET AL: "Chemometrics approach to the determination of polymorphism of a drug compound by infrared spectroscopy.", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. UNITED STATES FEB 2000, vol. 26, no. 2, February 2000 (2000-02-01), pages 135 - 147, XP002267858, ISSN: 0363-9045 *

Also Published As

Publication number Publication date
AU2003260294A1 (en) 2004-04-30
EP1567673A2 (fr) 2005-08-31
AU2003260294A8 (en) 2004-04-30
WO2004024949A2 (fr) 2004-03-25

Similar Documents

Publication Publication Date Title
WO2005094532A3 (fr) Reactions de codage et de decodage permettant de determiner des polynucleotides cibles
WO2002002823A3 (fr) Titrage de sequences polynucleotidiques
WO2009011971A3 (fr) Amorces et sondes pour la détection de streptococcus pneumoniae
WO2006023769A3 (fr) Determination de qualite de donnees et/ou d'aneusomie segmentaire l'aide d'un systeme informatique
CA2445370A1 (fr) Methode de reduction du temps d'analyse des profils de mesure en fin de reaction
WO2001036681A3 (fr) Detection immunologique d'arn: hybrides d'adn sur jeux ordonnes de microechantillons
WO2003100012A3 (fr) Jeux ordonnes de microechantillons et procede permettant de declencher une reaction d'hybridation pour plusieurs echantillons sur un seul jeu ordonne
AU9198298A (en) Polymorphism detection utilizing clustering analysis
EP1977002A1 (fr) Procede pour quantifier des acides nucleiques, notamment un adn traite au bisulfite
WO2003009100A3 (fr) Methodes, appareil et programmes informatiques de verification de l'integrite d'une sonde
Sina et al. DNA methylation-based point-of-care cancer detection: challenges and possibilities
WO2004024949A3 (fr) Procede de detection rapide de mutations et de polymorphismes nucleotidiques par chimiometrie
WO2001066804A3 (fr) Methodes permettant d'optimiser la capacite d'hybridation de sondes polynucleotidiques, et permettant de localiser et de detecter des variations de sequence
Amornpisutt et al. Validation of methylation-sensitive high resolution melting for the detection of DNA methylation in cholangiocarcinoma
WO2001098527A3 (fr) Procede pour l'analyse ultraparallele de polymorphismes
WO2009117031A3 (fr) Système et procédé pour le profilage de séquences nucléotidiques pour l’identification d’échantillons
AUPR221400A0 (en) Diagnostic assay
WO2004020603A3 (fr) Detection d'analytes
Aiba et al. Methylated site display (MSD)-AFLP, a sensitive and affordable method for analysis of CpG methylation profiles
WO2004000995A3 (fr) Procedes, sondes et molecules accessoires permettant de detecter des polymorphismes nucleotidiques uniques
Uccella et al. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression
IS6328A (is) Aðferð til að greina breytingar á metýleringu í 5. stöðu
WO2002090586A3 (fr) Methode et kit d'analyse
AU5096700A (en) Process for removing systematic error and outlier data and for estimating randomerror in chemical and biological assays
JP2008278783A (ja) 蛍光強度を指標とした遺伝子測定における異常値検出装置及び方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003794827

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003794827

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003794827

Country of ref document: EP